TOPARP: A Phase II Trial of Olaparib in Patients With Advanced Castration Resistant Prostate Cancer (TOPARP)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01682772 |
Recruitment Status :
Active, not recruiting
First Posted : September 11, 2012
Last Update Posted : August 15, 2019
|
Sponsor:
Institute of Cancer Research, United Kingdom
Collaborator:
Royal Marsden NHS Foundation Trust
Information provided by (Responsible Party):
Institute of Cancer Research, United Kingdom
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Active, not recruiting |
---|---|
Actual Primary Completion Date : | March 2019 |
Estimated Study Completion Date : | February 2020 |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):